1 |
BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424.
|
2 |
CHEN W Q, ZHENG R S, ZHANG S W, et al. Cancer incidence and mortality in China, 2013[J]. Cancer Lett, 2017, 401: 63-71.
|
3 |
GALADARI S, RAHMAN A, PALLICHANKANDY S, et al. Molecular targets and anticancer potential of sanguinarine: abenzophenanthridine alkaloid[J]. Phytomedicine, 2017, 34: 143-153.
|
4 |
ACHKAR I W, MRAICHE F, MOHAMMAD R M, et al. Anticancer potential of sanguinarine for various human malignancies[J]. Future Med Chem, 2017, 9(9): 933-950.
|
5 |
KUTTIKRISHNAN S, SIVEEN K S, PRABHU K S, et al. Sanguinarine suppresses growth and induces apoptosis in childhood acute lymphoblastic leukemia[J]. Leuk Lymphoma, 2019, 60(3): 782-794.
|
6 |
MA Y M, YU W, SHRIVASTAVA A, et al. Sanguinarine inhibits pancreatic cancer stem cell characteristics by inducing oxidative stress and suppressing sonic hedgehog-Gli-Nanog pathway[J]. Carcinogenesis, 2017, 38(10): 1047-1056.
|
7 |
ZHANG R, WANG G, ZHANG P F, et al. Sanguinarine inhibits growth and invasion of gastric cancer cells via regulation of the DUSP4/ERK pathway[J]. J Cell Mol Med, 2017, 21(6): 1117-1127.
|
8 |
FAN H N, CHEN W, PENG S Q, et al. Sanguinarine inhibits the tumorigenesis of gastric cancer by regulating the TOX/DNA-PKcs/KU70/80 pathway[J]. Pathol Res Pract, 2019, 215(11): 152677.
|
9 |
BARBIERI I, TZELEPIS K, PANDOLFINI L, et al. Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control[J]. Nature, 2017, 552(7683): 126-131.
|
10 |
ZHAO X, YANG Y, SUN B F, et al. FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis[J]. Cell Res, 2014, 24(12): 1403-1419.
|
11 |
WANG X, ZHAO B S, ROUNDTREE I A, et al. N6-methyladenosine modulates messenger RNA translation efficiency[J]. Cell, 2015, 161(6): 1388-1399.
|
12 |
CHEN X Y, ZHANG J, ZHU J S. The role of m6A RNA methylation in human cancer[J]. Mol Cancer, 2019, 18(1): 103.
|
13 |
WENG H Y, HUANG H L, WU H Z, et al. METTL14 inhibits hematopoietic stem/progenitor differentiation and promotes leukemogenesis via mRNA m6A modification[J]. Cell Stem Cell, 2018, 22(2): 191-205.e9.
|
14 |
WANG M, LIU J, ZHAO Y, et al. Upregulation of METTL14 mediates the elevation of PERP mRNA N6 adenosine methylation promoting the growth and metastasis of pancreatic cancer[J]. Mol Cancer, 2020, 19(1): 130.
|
15 |
YANG X, ZHANG S, HE C Y, et al. METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST[J]. Mol Cancer, 2020, 19(1): 46.
|
16 |
LIU X, XIAO M Y, ZHANG L, et al. The m6A methyltransferase METTL14 inhibits the proliferation, migration, and invasion of gastric cancer by regulating the PI3K/AKT/mTOR signaling pathway[J]. J Clin Lab Anal, 2021, 35(3): e23655.
|
17 |
张靖. 川楝素通过下调环状RNA circDLST对胃癌细胞BGC-823的抑制作用[J]. 上海交通大学学报(医学版), 2020, 40(9): 1202-1206.
|
18 |
WANG Q, CHEN C, DING Q Q, et al. METTL3-mediated m6A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance[J]. Gut, 2020, 69(7): 1193-1205.
|
19 |
YUE B, SONG C L, YANG L X, et al. METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer[J]. Mol Cancer, 2019, 18(1): 142.
|
20 |
WANG D, QU X J, LU W Q, et al. N6-methyladenosine RNA demethylase FTO promotes gastric cancer metastasis by down-regulating the m6A methylation of ITGB1[J]. Front Oncol, 2021, 11: 681280.
|
21 |
LI Y, ZHENG D Y, WANG F, et al. Expression of demethylase genes, FTO and ALKBH1, is associated with prognosis of gastric cancer[J]. Dig Dis Sci, 2019, 64(6): 1503-1513.
|
22 |
CHEN X Y, LIANG R, YI Y C, et al. The m6A reader YTHDF1 facilitates the tumorigenesis and metastasis of gastric cancer via USP14 translation in an m6A-dependent manner[J]. Front Cell Dev Biol, 2021, 9: 647702.
|
23 |
ZHU M, GONG Z Y, WU Q, et al. Sanguinarine suppresses migration and metastasis in colorectal carcinoma associated with the inversion of EMT through the Wnt/β-catenin signaling[J]. Clin Transl Med, 2020, 10(1): 1-12.
|
24 |
WANG H W, WANG H, LI K, et al. IGFBP-3 is the key target of sanguinarine in promoting apoptosis in hepatocellular carcinoma[J]. Cancer Manag Res, 2020, 12: 1007-1015.
|